Jae H. Park

Also affiliated with Memorial Sloan Kettering Cancer Center, Jacobi Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 48 papers. Top paper: “Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia”.

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia

Blood Advances(2022)10.1182/bloodadvances.2022008216

N/A

1.8DataRank · unranked

72 citations

Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae H. Park, Matthew J. Wieduwilt +12 more

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30209-x

N/A

0.843DataRank · unranked

21 citations

Xiaoli Mi, Alexander Penson, Stella Paffenholz, Kelsey Alvarez, Allison Sigler +10 more

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

Leukemia(2021)10.1038/s41375-021-01257-7

N/A

0.578DataRank · unranked

46 citations

Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly +34 more

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010003

N/A

0.470DataRank · unranked

22 citations

Soo‐Jeong Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M Hanley +19 more

Atrial arrhythmias following CAR‐chimeric antigen receptor T‐cell therapy: Incidence, risk factors and biomarker profile

British Journal of Haematology(2024)10.1111/bjh.19497

N/A

0.434DataRank · unranked

17 citations

Adam Goldman, Jessica Flynn, Ahmed El‐Moghraby, Mahin Rehman, Sean M. Devlin +20 more

Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-24-0163

N/A

0.396DataRank · unranked

13 citations

Susan DeWolf, Teng Fei, Sandeep Raj, Gunjan L. Shah, Caleb A. Lareau +18 more

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol

eJHaem(2024)10.1002/jha2.991

N/A

0.297DataRank · unranked

5 citations

Ju‐Whei Lee, David F. Claxton, Elisabeth Paietta, Hassan B. Alkhateeb, Jae H. Park +8 more

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017526

N/A

0.267DataRank · unranked

3 citations

Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski, Kevin J. Curran +43 more

Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012436

N/A

0.244DataRank · unranked

4 citations

Flavia Gava, Yannis K. Valtis, Toshihisa Satta, Surabhi B Vora, Joseph M. Rocco +9 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

medRxiv(2022)10.1101/2022.10.03.22280675

N/A

0DataRank · unranked

1 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

Research Square(2022)10.21203/rs.3.rs-2094202/v1

N/A

0DataRank · unranked

0 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02404-6

N/A

0DataRank · unranked

167 citations

Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah +14 more

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Cancer Cell(2023)10.1016/j.ccell.2023.09.010

N/A

0DataRank · unranked

113 citations

Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina +9 more

Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients

European Heart Journal(2023)10.1093/eurheartj/ehad117

N/A

0DataRank · unranked

49 citations

Peter A. Riedell, Stephanie Feldman, Gina George, Stephen Sansoterra, Thomas Althaus +29 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications(2023)10.1038/s41467-023-42585-9

N/A

0DataRank · unranked

29 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal

Blood Advances(2023)10.1182/bloodadvances.2022009212

N/A

0DataRank · unranked

22 citations

Brian C. Shaffer, Bhavana Bhatnagar, Alice S. Mims, Victoria Klein, Deepika Dilip +9 more

Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology

Journal of Molecular Diagnostics(2023)10.1016/j.jmoldx.2023.06.002

N/A

0DataRank · unranked

3 citations

Utsav Patel, Amir Momeni Boroujeni, JinJuan Yao, Roger Chan, Joe Chan +18 more

Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

(2023)10.1158/1078-0432.c.6532596

N/A

0DataRank · unranked

0 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

(2023)10.1158/1078-0432.c.6532596.v1

N/A

0DataRank · unranked

0 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01540-x

N/A

0DataRank · unranked

39 citations

Jessica Flynn, Sean M. Devlin, Audrey Mauguen, Teng Fei, Shang Zeng +23 more

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.027

N/A

0DataRank · unranked

13 citations

Roni Shouval, Jessica Flynn, Sean M. Devlin, Amethyst Saldia, Alejandro Luna +16 more

Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.10.010

N/A

0DataRank · unranked

12 citations

Alejandro Luna, Gunjan L. Shah, Sean M. Devlin, Magdalena Corona, Joshua Fein +13 more

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Blood Advances(2024)10.1182/bloodadvances.2024014555

N/A

0DataRank · unranked

13 citations

Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna +15 more

Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia

Blood Neoplasia(2024)10.1016/j.bneo.2024.100038

N/A

0DataRank · unranked

3 citations

Yannis K. Valtis, Andriy Derkach, Meira Yisraeli Salman, Leora Boussi, Jenna Ciervo +7 more

HMA/VEN treatment modifications and associated outcomes in IDH -mutant AML

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2411436

N/A

0DataRank · unranked

2 citations

Andriy Derkach, Christopher Famulare, Gaurav K. Gupta, P. Dayand Borge, Mark B. Geyer +8 more

CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.26.582108

N/A

0DataRank · unranked

11 citations

Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib +14 more

Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma

Research Square(2024)10.21203/rs.3.rs-4619285/v1

N/A

0DataRank · unranked

2 citations

M. Lia Palomba, Karlo Perica, Sean M. Devlin, Gunjan L. Shah, Parastoo B. Dahi +28 more

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

New England Journal of Medicine(2025)10.1056/nejmoa2411507

N/A

0DataRank · unranked

86 citations

Nayan Jain, Michael Scordo, Ruchi Patel, Özgür Can Eren, Utsav Patel +21 more

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood(2025)10.1182/blood.2025028833

N/A

0DataRank · unranked

34 citations

Jaime Sanz, Teng Fei, Monica Nair, Hamza Hashmi, Abraham Avigdor +32 more

Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts

Blood Advances(2025)10.1182/bloodadvances.2024015441

N/A

0DataRank · unranked

31 citations

Ibrahim Aldoss, Daniel J. DeAngelo, Marina Konopleva, Jessica Leonard, Aaron C. Logan +5 more

CAR-engineered lymphocyte persistence is governed by a FAS ligand–FAS autoregulatory circuit

Nature Cancer(2025)10.1038/s43018-025-01009-x

N/A

0DataRank · unranked

30 citations

Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib +18 more

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

Blood Cancer Journal(2025)10.1038/s41408-025-01321-w

N/A

0DataRank · unranked

11 citations

Stephanie Lobaugh, Danny Luan, Marina Gómez-Llobell, P Subramanian, Sean M. Devlin +22 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1

N/A

0DataRank · unranked

8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

Blood Advances(2025)10.1182/bloodadvances.2025017011

N/A

0DataRank · unranked

7 citations

Richard Aplenc, Susanne H.C. Baumeister, Marco Becilli, Anand Bhagwat, Challice L. Bonifant +30 more

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01273-1

N/A

0DataRank · unranked

4 citations

Sean M. Devlin, Kai Rejeski, Jessica Flynn, Magdalena Corona, Efrat Luttwak +21 more

Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.017

N/A

0DataRank · unranked

2 citations

Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin, Olayode Babatunde +12 more

Venetoclax in Combination With Pediatric‐Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial

American Journal of Hematology(2025)10.1002/ajh.70082

N/A

0DataRank · unranked

1 citations

David Nemirovsky, Andriy Derkach, I. Cacace, Martina Torres, Colleen Finneran +6 more

Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic Malignancies

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.09.012

N/A

0DataRank · unranked

0 citations

Rachel Reingold, Rose Parisi, Stephen W. Dusza, Sarah Noor, Jae H. Park +9 more

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Blood Advances(2020)10.1182/bloodadvances.2020001956

N/A

0DataRank · unranked

86 citations

Peter Dreger, Jennifer R. Brown, Oscar Lahoud, Toby A. Eyre, Danielle M. Brander +20 more

Patterns and safety of glucocorticosteroid use following CD19 CAR‐T therapy for large B‐cell lymphoma

HemaSphere(2025)10.1002/hem3.70248

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Sean M. Devlin, Alexander P. Boardman, Giulio Cassanello, Magdalena Corona +19 more

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon

Leukemia Research Reports(2020)10.1016/j.lrr.2020.100211

N/A

0DataRank · unranked

8 citations

Zoe McKinnell, Jae H. Park, Eytan M. Stein, Sheng F. Cai, Justin Taylor +1 more

Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection

Molecular Therapy(2021)10.1016/j.ymthe.2021.06.022

N/A

0DataRank · unranked

19 citations

Christopher M. Bourne, Megan M. Dacek, Enver Akalin, Jae H. Park, Eric L. Smith +2 more

The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis

Blood(2022)10.1182/blood.2022016194

N/A

0DataRank · unranked

88 citations

Michael Slade, Hagop M. Kantarjian, Julio Alvarenga, Ibrahim Aldoss, Kahee A. Mohammed +16 more

Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3712

N/A

0DataRank · unranked

64 citations

Michael R. McDevitt, Jorge A. Carrasquillo, Neeta Pandit‐Taskar, Mark G. Frattini, P. Maslak +7 more

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004128

N/A

0DataRank · unranked

36 citations

David Qualls, Sébastien Monette, Shenon Sethi, Ahmet Doǧan, Mikhail Roshal +8 more

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

Blood Cancer Journal(2022)10.1038/s41408-022-00760-z

N/A

0DataRank · unranked

23 citations

Robert J. Kreitman, Enrico Tiacci, Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos +40 more

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0964

N/A

0DataRank · unranked

13 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

Molecular Therapy(2022)10.1016/j.ymthe.2022.12.006

N/A

0DataRank · unranked

11 citations

Jing Yao, Kimberley House, Lisa Duffy, Prasad S. Adusumilli, Rachel K. Beyer +26 more